Brian Lian

Insider Reports History

Entity
Individual
Location
C/O Seelos Therapeutics, Inc., 300 Park Avenue, 12 Th Floor, New York, NY
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Lian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. President & CEO, Director Common Stock, par value $0.00001 per share 2.27M $189M $83.34 Mar 27, 2024 Direct
Viking Therapeutics, Inc. President & CEO, Director Common Stock, par value $0.00001 per share 2.3M $166M $71.99 Sep 20, 2024 Direct
Viking Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 65K Sep 20, 2024 Direct
SEELOS THERAPEUTICS, INC. Director Stock Option (right to buy) 1.67K Jan 4, 2024 Direct

Insider Reports Filed by Brian Lian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VKTX Viking Therapeutics, Inc. Sep 20, 2024 5 -$14M 4 Sep 20, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Aug 21, 2024 3 -$62.1K 4 Aug 22, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Aug 19, 2024 5 -$6.55M 4 Aug 19, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Jul 29, 2024 5 -$6.67M 4 Jul 31, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Mar 27, 2024 2 -$12.8M 4 Mar 27, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Mar 1, 2024 2 -$13.9M 4 Mar 4, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Feb 9, 2024 1 -$1.35M 4 Feb 9, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Feb 8, 2024 10 -$6.52M 4 Feb 8, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Jan 31, 2024 4 -$2M 4 Jan 31, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. Jan 30, 2024 3 -$795K 4 Jan 30, 2024 President & CEO, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 4, 2024 1 $0 4 Jan 8, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2024 6 -$4.47M 4 Jan 4, 2024 President & CEO, Director
VKTX Viking Therapeutics, Inc. May 1, 2023 1 -$1.01M 4 May 1, 2023 President & CEO, Director
VKTX Viking Therapeutics, Inc. Apr 19, 2023 1 -$751K 4 Apr 21, 2023 President & CEO, Director
VKTX Viking Therapeutics, Inc. Apr 17, 2023 3 -$2.9M 4 Apr 18, 2023 President & CEO, Director
VKTX Viking Therapeutics, Inc. Apr 13, 2023 3 -$1.36M 4 Apr 13, 2023 President & CEO, Director
VKTX Viking Therapeutics, Inc. Mar 30, 2023 12 -$6.75M 4 Apr 3, 2023 President & CEO, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 5, 2023 1 $0 4 Jan 5, 2023 Director
VKTX Viking Therapeutics, Inc. Dec 30, 2022 6 -$1.44M 4 Jan 4, 2023 President & CEO, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 5, 2022 1 $0 4 Jan 6, 2022 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2022 4 -$299K 4 Jan 5, 2022 President & CEO, Director
VKTX Viking Therapeutics, Inc. Sep 28, 2021 2 -$180K 4 Sep 30, 2021 President & CEO, Director